1,462
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Antiretroviral drug-loaded nanoparticles-in-films: a new option for developing vaginal microbicides?

ORCID Icon & ORCID Icon
Pages 449-452 | Received 26 Oct 2016, Accepted 06 Dec 2016, Published online: 14 Dec 2016

References

  • D’Cruz OJ, Uckun FM. Vaginal microbicides and their delivery platforms. Expert Opin Drug Deliv. 2014;11(5):723–740.
  • Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010 Sep 3;329(5996):1168–1174.
  • Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016 Feb 22. DOI:10.1056/NEJMoa1506110
  • Chen BA, Panther L, Marzinke MA, et al. Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings: a double-blind randomized trial. J Acquir Immune Defic Syndr. 2015 May 28;70(3):242–249.
  • Kashuba AD, Gengiah TN, Werner L, et al. Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):264–269.
  • das Neves J, Nunes R, Rodrigues F, et al. Nanomedicine in the development of anti-HIV microbicides. Adv Drug Deliv Rev. 2016;103:57–75.
  • Sepúlveda-Crespo D, Ceña-Díez R, Jiménez JL, et al. Mechanistic studies of viral entry: an overview of dendrimer-based microbicides as entry inhibitors against both HIV and HSV-2 overlapped infections. Med Res Rev. 2016 Aug 12. DOI:10.1002/med.21405
  • das Neves J, Araújo F, Andrade F, et al. Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice. Pharm Res. 2014;31(7):1834–1845.
  • Kovarova M, Council OD, Date AA, et al. Nanoformulations of rilpivirine for topical pericoital and systemic coitus-independent administration efficiently prevent HIV transmission. Plos Pathog. 2015 Aug;11(8):e1005075.
  • Rohan LC, Zhang W. Vaginal microbicide films. In: das Neves J, Sarmento B, editors. Drug delivery and development of anti-HIV microbicides. Singapore: Pan Stanford; 2014. p. 291–330.
  • Srinivasan P, Zhang J, Martin A, et al. Safety and pharmacokinetics of quick dissolving polymeric vaginal films delivering the antiretroviral IQP-0528 for pre-exposure prophylaxis. Antimicrob Agents Chemother. 2016 May 2;60(7):4140–4150.
  • Machado A, Cunha-Reis C, Araújo F, et al. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system. Acta Biomater. 2016 Aug;17(44):332–340.
  • Gu J, Yang S, Ho EA. Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells. Mol Pharm. 2015 Aug 3; 12(8):2889–2903.
  • Cunha-Reis C, Machado A, Barreiros L, et al. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs. J Control Release. 2016 Sep;21(243):43–53.
  • Krogstad EA, Kraft JC, Blakney AK, et al. Sustained delivery of etravirine from nanoparticle-releasing nanofiber composites after vaginal administration in mice. AIDS Res Hum Retroviruses. 2016;32(S1):214.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.